• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Top 4 Defensive Stocks You'll Regret Missing This Quarter

    5/2/24 8:56:24 AM ET
    $COOT
    $MED
    $SHOT
    $TAP
    Packaged Foods
    Consumer Staples
    Packaged Foods
    Consumer Staples
    Get the next $COOT alert in real time by email

    The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

    The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href=”https://www.benzinga.com/topic/rsi”> RSI is below 30</a>, according to Benzinga Pro.

    Here's the latest list of major oversold players in this sector, having an RSI near or below 30.

    Medifast, Inc. (NYSE:MED)

    • On April 29, Medifast reported mixed first-quarter financial results. “Fast paced medical innovation is providing greater access to medical weight loss solutions than ever before. We are transforming our OPTAVIA offer to include comprehensive support for consumers who wish to use GLP-1 medical weight loss solutions on their individual journeys to sustainable healthy lifestyles, Chairman & Chief Executive Officer. The company's stock fell around 21% over the past five days and has a 52-week low of $25.92.
    • RSI Value: 28.64
    • MED Price Action: Shares of Medifast fell 4.3% to close at $26.36 on Wednesday.

    Safety Shot, Inc. (NASDAQ:SHOT)         

    • On April 9, Safety Shot said the Nelk Boys have joined forces with Safety Shot as brand ambassadors. The company's stock fell around 35% over the past month. It has a 52-week low of $0.3050.
    • RSI Value: 29.61
    • SHOT Price Action: Shares of Safety Shot fell 9.2% to close at $1.39 on Wednesday.

    Molson Coors Beverage Company (NYSE:TAP)

    • On April 30, Molson Coors Beverage reported first-quarter FY24 sales growth of 10.7% year-on-year to $2.60 billion, beating the analyst consensus estimate of $2.50 billion. "Strong America's volume and favorable net pricing across both business units resulted in double-digit top-line growth while volume leverage and ongoing cost savings drove meaningful margin expansion in the quarter," said CFO Tracey Joubert. The company's shares fell around 11% over the past five days and has a 52-week low of $55.67.
    • RSI Value: 22.34
    • TAP Price Action: Shares of Molson Coors Beverage fell 0.3% to close at $57.08 on Wednesday.

    Australian Oilseeds Holdings Limited (NASDAQ:COOT)

    • On April 25, Australian Oilseeds secured contracts with Woolworths and Costco for non-GMO cold-pressed oils. The company's shares lost around 7% over the past five days. The company's 52-week low is $1.14.
    • RSI Value: 28.98
    • COOT Price Action: Shares of Australian Oilseeds Holdings rose 1.1% to close at $1.3350 on Wednesday.
    Get the next $COOT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $COOT
    $MED
    $SHOT
    $TAP

    CompanyDatePrice TargetRatingAnalyst
    Molson Coors Beverage Company
    $TAP
    1/16/2026$40.00Neutral → Underperform
    BNP Paribas Exane
    Molson Coors Beverage Company
    $TAP
    11/19/2025$50.00Overweight → Equal Weight
    Wells Fargo
    Molson Coors Beverage Company
    $TAP
    11/7/2025$49.00Neutral
    Analyst
    Molson Coors Beverage Company
    $TAP
    9/12/2025$50.00Equal Weight → Underweight
    Barclays
    Molson Coors Beverage Company
    $TAP
    6/27/2025$50.00Buy → Neutral
    BofA Securities
    Molson Coors Beverage Company
    $TAP
    4/2/2025$86.90Buy
    Berenberg
    Molson Coors Beverage Company
    $TAP
    3/13/2025$56.00 → $62.00Underweight → Equal Weight
    Barclays
    Molson Coors Beverage Company
    $TAP
    2/5/2025$47.00 → $57.00Sell → Neutral
    Citigroup
    More analyst ratings

    $COOT
    $MED
    $SHOT
    $TAP
    SEC Filings

    View All

    SEC Form 6-K filed by Australian Oilseeds Holdings Limited

    6-K - Australian Oilseeds Holdings Ltd (0001959994) (Filer)

    1/30/26 4:05:10 PM ET
    $COOT
    Packaged Foods
    Consumer Staples

    SEC Form 6-K filed by Australian Oilseeds Holdings Limited

    6-K - Australian Oilseeds Holdings Ltd (0001959994) (Filer)

    1/29/26 9:50:19 PM ET
    $COOT
    Packaged Foods
    Consumer Staples

    SEC Form 6-K filed by Australian Oilseeds Holdings Limited

    6-K - Australian Oilseeds Holdings Ltd (0001959994) (Filer)

    1/13/26 4:05:28 PM ET
    $COOT
    Packaged Foods
    Consumer Staples

    $COOT
    $MED
    $SHOT
    $TAP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    Medifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full year ended December 31, 2025 on Tuesday, February 17, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on February 17, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www

    2/3/26 4:05:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings

    ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. Baystreet.ca News Commentary  VANCOUVER, BC, Jan. 19, 2026 /PRNewswire/ -- The global consumer healthcare market is hitting a massive structural wall, projected to reach $362.17 billion in 2026[1]. In this high-stakes environment, commercial survival is no longer just about the product; it hinges on precision regulatory execution. Eight key regulatory and compliance pressures[2] are reshaping sector strategy, forcing a capital rotation into a first-mover cohort that includes Doseology Sciences Inc. (CSE:MOOD) (OTCPK:DOSEF) (FSE: VU70), Philip Morris (NYSE:PM), Celsius Holdings (NASDAQ:CELH), USANA Health Sciences (NYSE:USNA), and Medifast (NYSE:MED

    1/19/26 12:10:00 PM ET
    $CELH
    $MED
    $PM
    Beverages (Production/Distribution)
    Consumer Staples
    Packaged Foods
    Medicinal Chemicals and Botanical Products

    Molson Coors Beverage Company Announces 2025 Fourth Quarter and Full Year Earnings Date and Participation at the 2026 Consumer Analyst Group of New York (CAGNY) Conference

    Molson Coors Beverage Company (NYSE:TAP, TAP.A, TSX:TPX, TPX.A)) will release its 2025 Fourth Quarter and Full Year earnings results on Wednesday, February 18, 2026 at approximately 4 p.m. Eastern Time. That same day, the company will participate in the 2026 Consumer Analyst Group of New York (CAGNY) Conference. The presentation is scheduled for 5 p.m. Eastern Time. Chief Executive Officer Rahul Goyal and Chief Financial Officer Tracey Joubert will discuss the company's business strategies and 2026 medium-term financial outlook. The presentation will be available via live webcast on the company's investor relations website, with a replay accessible until August 18, 2026. Due to the deta

    1/9/26 7:00:00 AM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    $COOT
    $MED
    $SHOT
    $TAP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cocks Christian P bought $2,123 worth of Class B Common Stock (45 units at $47.19), increasing direct ownership by 0.98% to 4,634 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    2/6/26 7:20:21 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Director Molson Andrew Thomas bought $350,924 worth of Class B Common Stock (7,500 units at $46.79), increasing direct ownership by 49% to 22,654 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    11/12/25 8:33:18 AM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Director Coors David S. bought $99,824 worth of Class B Common Stock (2,245 units at $44.47), increasing direct ownership by 8% to 30,586 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    11/6/25 5:27:43 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    $COOT
    $MED
    $SHOT
    $TAP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $COOT
    $MED
    $SHOT
    $TAP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Director Cocks Christian P bought $2,123 worth of Class B Common Stock (45 units at $47.19), increasing direct ownership by 0.98% to 4,634 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    2/6/26 7:20:21 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Director Cocks Christian P was granted 616 units of Class B Common Stock, increasing direct ownership by 16% to 4,589 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    1/2/26 4:22:37 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Director Herington Charles M was granted 308 units of Class B Common Stock, increasing direct ownership by 0.51% to 61,251 units (SEC Form 4)

    4 - MOLSON COORS BEVERAGE CO (0000024545) (Issuer)

    1/2/26 4:22:12 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Molson Coors Brewing downgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane downgraded Molson Coors Brewing from Neutral to Underperform and set a new price target of $40.00

    1/16/26 8:32:26 AM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Molson Coors Brewing downgraded by Wells Fargo with a new price target

    Wells Fargo downgraded Molson Coors Brewing from Overweight to Equal Weight and set a new price target of $50.00

    11/19/25 8:55:02 AM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Analyst resumed coverage on Molson Coors Brewing with a new price target

    Analyst resumed coverage of Molson Coors Brewing with a rating of Neutral and set a new price target of $49.00

    11/7/25 8:02:02 AM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    $COOT
    $MED
    $SHOT
    $TAP
    Leadership Updates

    Live Leadership Updates

    View All

    Medifast Announces Planned Leadership Transition

     Nicholas Johnson Appointed President, and Expected to Succeed Dan Chard as CEO in June 2026; Chard to Remain Chairman Medifast, Inc. (NYSE:MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabolic health. Medifast Chairman & Chief Executive Officer Dan Chard has informed the Board of Directors that he plans to step down as Chief Executive Officer in June 2026. Chard will continue to serve as Chairman of the Board following the transition. The Board has appointed Medifast's Chief Field Operations Officer Nicholas Johnson as President of Medifast, effective immediately. Johnson will work clo

    1/5/26 9:00:00 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    Safety Shot Provides Further Details on Strategic Board Refresh and Corporate Vision

    Company to Seek Shareholder Approval for New Director Appointments SCOTTSDALE, AZ, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Following its announcement yesterday regarding a strategic refresh of its Board of Directors, Safety Shot, Inc. (NASDAQ:SHOT) is providing further details on the implementation of these changes. The appointment of the three new directors, as well as the resignations of Jordan Schur and Rich Pascucci, will not be effective until the Company achieves shareholder approval which is anticipated to take place in October. In addition, as the Company previously announced, it has reserved the trading symbol "BNKK" with Nasdaq as part of its forward-looking strategy. The Company w

    9/18/25 9:06:00 AM ET
    $SHOT
    Package Goods/Cosmetics
    Consumer Discretionary

    Safety Shot Announces Strategic Board Refresh to Align with New Corporate Vision

    Company Appoints New Directors with Deep Expertise in Venture Capital, Financial Due Diligence, and Bitcoin Mining to Guide Next Phase of Growth SCOTTSDALE, AZ, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (NASDAQ:SHOT) today announced a strategic refresh of its Board of Directors with the appointment of three new members: Connor Klein, an investment partner at New Form Capital; Stacey Duffy, a seasoned financial due diligence and transaction advisory expert; and Jamie McAvity, co-founder and CEO of Bitcoin miner Cormint, Inc. The new appointments are designed to provide the Company with enhanced expertise in digital assets, capital markets, and high-growth operations as it execu

    9/17/25 8:30:00 AM ET
    $SHOT
    Package Goods/Cosmetics
    Consumer Discretionary

    $COOT
    $MED
    $SHOT
    $TAP
    Financials

    Live finance-specific insights

    View All

    Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    Medifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter and full year ended December 31, 2025 on Tuesday, February 17, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on February 17, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www

    2/3/26 4:05:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Molson Coors Beverage Company Announces 2025 Fourth Quarter and Full Year Earnings Date and Participation at the 2026 Consumer Analyst Group of New York (CAGNY) Conference

    Molson Coors Beverage Company (NYSE:TAP, TAP.A, TSX:TPX, TPX.A)) will release its 2025 Fourth Quarter and Full Year earnings results on Wednesday, February 18, 2026 at approximately 4 p.m. Eastern Time. That same day, the company will participate in the 2026 Consumer Analyst Group of New York (CAGNY) Conference. The presentation is scheduled for 5 p.m. Eastern Time. Chief Executive Officer Rahul Goyal and Chief Financial Officer Tracey Joubert will discuss the company's business strategies and 2026 medium-term financial outlook. The presentation will be available via live webcast on the company's investor relations website, with a replay accessible until August 18, 2026. Due to the deta

    1/9/26 7:00:00 AM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    Molson Coors Beverage Company Announces Regular Quarterly Dividend

    The Board of Directors of Molson Coors Beverage Company (NYSE:TAP, TAP.A)) today declared a regular quarterly dividend on its Class A and Class B common stock of US$0.47 per share, payable December 19, 2025, to stockholders of record on December 5, 2025. The quarterly dividend is payable to holders of Class A and Class B common stock of Molson Coors Beverage Company. In addition, the Board of Directors of Molson Coors Canada Inc. (TSX:TPX, TPX.A)) today declared a quarterly dividend of approximately CAD$0.66 (the Canadian dollar equivalent of the dividend declared on Molson Coors Beverage Company stock), payable December 19, 2025, to its Class A and Class B exchangeable shareholders of re

    11/20/25 6:13:00 PM ET
    $TAP
    Beverages (Production/Distribution)
    Consumer Staples

    $COOT
    $MED
    $SHOT
    $TAP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Australian Oilseeds Holdings Limited

    SC 13G/A - Australian Oilseeds Holdings Ltd (0001959994) (Subject)

    11/12/24 3:48:27 PM ET
    $COOT
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Safety Shot Inc.

    SC 13G/A - Safety Shot, Inc. (0001760903) (Subject)

    9/5/24 4:52:33 PM ET
    $SHOT
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by MEDIFAST INC

    SC 13G/A - MEDIFAST INC (0000910329) (Subject)

    7/10/24 1:14:41 PM ET
    $MED
    Packaged Foods
    Consumer Staples